Abstract
It is firmly established that cytokines are involved in development of hematopoietic cells. Until recently it was not known whether cytokines are involved in development of lymphoid cells. Initially, interleukin (IL)-2 and IL-4 were considered to be candidates essential for lymphoid development. However, this turned out not to be the case since mice deficient for IL-2 [1], IL-4 [2] or both [3] had no obvious defects with regard to development of T and B cells. Nonetheless, it became clear that cytokines do play an essential role in T cell development when the molecular defect underlying the X chromosome linked severe combined immunodeficiency (X-SCID) was determined [4]. These patients have no T or NK cells but B cells are present in normal numbers. It turned out that these patients have mutations in the gamma chain of the IL-2 receptor complex [4]. As it was already known that IL-2 is not essential for T cell development, it was suspected that this component of the IL-2R was also part of receptors for other cytokines. This suspicion was confirmed soon thereafter when it was found that the IL-2Rγ chain is also a component of the receptors of IL-4, IL-7, IL-9 and IL-15 [5–7]. Therefore, the IL-2Rγ chain is now commonly referred to as the gamma common (γc) chain. Studies with IL-7 [8] and IL-7Rα chain deficient mice [9] havve made clear that IL-7 is the critical γc ligand involved in T cell development. Like the γc deficient mice [10], these mice have a thymus that is only 10% in size of the wild type thymus.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991;352: 621–24.
Kuhn R, Rajewski K, Muller W. Generation and analysis of Interleukin-4 deficient mice. Science 1991;254:707–10.
Sadlack B, Kuhn R, Schorle H, Rajewski K, Muller W, Horak I. Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4. Eur J Immunol 1994;24:281–84.
Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993;73: 147–57.
Noguchi M, Nakamura Y, Russell SM, et al. Interleukin-2 receptor gamma chain: A functional component of the interleukin-7 receptor. Science 1993;262:1877–80.
Kondo M, Takeshita T, Ishii N, et al. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 1993;262:1874–77.
Russell SM, Keegan AD, Harada N, et al. Interleukin-2 receptor γi chain: A functional component of the interleukin-4 receptor. Science 1993;262:1880–83.
Von Freeden B, Jeffry U, Vieira P, et al. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995; 181:1519–26.
Peschon JJ, Morrissey PJ, Grahstein KH, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994;1804:1955–60.
DiSanto JP, Muller W, Guy GD, Fischer A, Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci USA 1995;92:377–81.
Cao X, Shores EW, Hu LJ, et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995;2:223–38.
Plum J, De Smedt M, Leclercq G, Verhasselt B, Vanderkerckhove B. Interleukin-7 is a critical growth factor in early human T-cell development. Blood 1996;88:4239–45.
Prieyl JA, LeBien TW. Interleukin 7 independent development of human B cells. Proc Natl Acad Sei USA 1996;93:10348–53.
Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 1993;74:823–32.
Yang E, Korsmeyer SJ. Molecular thanatopsis: A discourse on the Bcl-2 family and cell death. Blood 1996;88:386–401.
McDonnell TJ, Nunez G, Platt FM, et al. Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol Cell Biol 1990;10:1901–7.
DiSanto JP, Guy GD, Fisher A, Tarakhovsky A. Critical role for the common cytokine receptor gamma chain in intrathymic and peripheral T cell selection. J Exp Med 1996; 183:1111–18.
Corcoran AE, Smart FM, Cowling RJ, Crompton T, Owen MJ, Venkitaraman AR. The interleukin-7 receptor alpha chain transmits distinct signals for proliferation and differ-entiation during B lymphopoiesis. EMBO J 1996;15:1924–32.
Voss SD, Hong R, Sondel PM. Severe combined immunodeficiency, interleukin-2 (IL-2), and the IL-2 receptor: experiments of nature continue to point the way. Blood 1994;83:626–35.
Suzuki H, Duncan GS, Takimoto H, Mak TW. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. J Exp Med 1997;185:499–505.
Grabstein KH, Eisenman J, Shanebeck K, et al. Cloning of a T cell growth factor that interacts with the β chain of the Interleukin-2 receptor. Science 1994;264:965–68.
Puzanov IJ, Bennett M, Kumar V. IL-15 can substitute for the marrow micro-environment in the differentiation of natural killer cells. J Immunol 1996;157:4282–85.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Kluwer Academic Publishers
About this chapter
Cite this chapter
Blom, B., Spits, H., Krimpenfort, P. (1997). The Role of the Common Gamma Chain of the IL-2, IL-4, IL-7 and IL-15 Receptors in Development of Lymphocytes. Constitutive Expression of Bcl-2 does not Rescue the Developmental Defects in Gamma Common-Deficient Mice. In: Sibinga, C.T.S., Das, P.C., Löwenberg, B. (eds) Cytokines and Growth Factors in Blood Transfusion. Developments in Hematology and Immunology, vol 32. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1137-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1137-9_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8435-2
Online ISBN: 978-1-4613-1137-9
eBook Packages: Springer Book Archive